On the evening of 10th May 2025, I had the pleasure of speaking at EMVOLUTION, an educational empagliflozin workshop hosted by Qualitas Health in collaboration with Boehringer Ingelheim, held at the Royale Chulan Damansara. The event, themed “Empagliflozin’s Revolutionary Management in CRM Continuum”, gathered healthcare professionals for a dynamic discussion on the evolving landscape of chronic disease management.
I was honoured to present on “Managing the ‘Tough Guys’: Patients with Co-morbidities,” where I shared practical approaches to handling complex patient profiles—particularly those with overlapping cardiovascular, renal, and metabolic conditions. As we continue to embrace newer therapies like empagliflozin, it’s clear that we’re entering a new era of patient-centric, multi-disciplinary care.
Dr. Wong Mun Hoe from Pantai Hospital Kuala Lumpur followed with a compelling session titled “The Silent Killer: CKD,” shining a spotlight on the silent burden of chronic kidney disease. We wrapped up with a lively panel discussion in the spirit of a “Tonight Show”, exchanging insights across specialties.
Thanks to all who attended and contributed to the rich dialogue. Events like these remind us of the importance of collaboration in advancing patient outcomes.
